The landscape of emerging technologies and how these can impact
veterinary vaccines (prophylactic and curative, infectious and non-infectious diseases (e.g. diabetes, allergy, cancer) and biologicals
Adaptable vaccines (emerging strains and variants) and individualized
therapies
mRNA/DNA-technology
Protein/antigen expression, plug & play
Delivery of the biological (vectors, nanoparticles, targeting …)
Developments that need to occur or are under development to make
the technologies viable in an animal health market (i.e. avoid cold chain for mRNA; acceptable cost of goods)
Links between new scientific developments and market potential/
needs: where can the technologies bring the solution to unmet needs
(e.g. ASF-vaccine, gene therapy, …)?
